Clinical Trial Update: Comparison of Biphasic Insulin Aspart (30, 50 and 70) and Insulin Aspart in Healthy Subjects [Phase 1]

View source ↗

Summary

A Phase 1 study comparing biphasic insulin aspart 30, 50 and 70 formulations with insulin aspart in healthy subjects to assess safety and pharmacokinetic/pharma…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetes Mellitus

Drugs mentioned

• Insulin aspart (insulin aspart)
• NovoMix 30 (insulin aspart protamine fixed-dose combination)
• NovoMix 50 (biphasic insulin aspart 50)
• NovoMix 70 (insulin aspart 70/30)

Snippet

Sponsor: Novo Nordisk A/S | Conditions: Diabetes, Healthy | Phase 1 | Status: COMPLETED